February 1, 2018
Mylan launches Efavirenz in USA, first generic version of BMS’s HIV type 1 treatment Sustiva
Mylan is launching Efavirenz Tablets USP, 600 mg, in the USA, the first generic version of Bristol-Myers Squibb’s Sustiva, which…
